ASAM serves its members in many ways. One of the most important ways is by helping to play an active role in shaping government policies that affect their livelihoods and the lives of their patients.

ASAM advocates for policies that promote access to high-quality treatment and recovery support services for the 22 million Americans who suffer from a substance use disorder. The information here will help you stay up to date on emerging issues, enable you to take action and become an advocate for your patients and your practice, and learn about how ASAM is working with government, insurers and other national organizations to promote policies that advance addiction medicine.


Opioid misuse and overdose are a public health crisis in the United States.  ASAM and others have come together as the Coalition to Stop Opioid Overdose to advance meaningful legislative and regulatory policies this year in response to the opioid epidemic.

2016 NPF Training_472x176 

2018 NPF Training

Audio, text, slides, photos and selected 5-minute videos segments from the 2018 NPF/ ASAM Training held at the 49th ASAM Annual Conference in San Diego, CA.

Advocacy Toolkits_472x176

Advocacy Toolkits

Access resources that will equip you to advocate effectively for policies that promote addiction treatment and prevention.

Advocacy Events_472x176

Advocacy Issues

Find the latest information on issues of importance to the field of addiction medicine.

NPF training_472x176

Advocacy News

News and information about ASAM Advocacy.

Find a Policy Statement_472x176

Find a Policy Statement

Learn about ASAM's position on current policy issues.


Kelly Corredor
Director, Advocacy and Government Relations | 301.547.4111


Susan Awad
Policy Advisor | 301.547.4103


Corey Barton
Manager, Private Sector Relations | 301.547.4106


Brad Bachman
Manager, State Advocacy and Government Relations | 301.547.4107


Connor Galvin
Specialist, Federal Advocacy and Policy | 301.547.4135

Committee Chairs

Corey Waller, MD, MS, FACEP
Flora Sadri, DO, MPF, FAAFP

Chair and Vice Chair, Legislative Advocacy Committee


Jeffrey Selzer, MD, DFASAM
Randolph Holmes, MD, FASAM

Chair and Vice Chair, Public Policy Committee


Shawn Ryan, MD, MBA, FASAM
Frank James, MD, JD

Chair and Vice Chair, Payer Relations Committee

Advocacy Articles

ASAM Applauds Walmart’s Launch of DisposeRx

by ASAM Staff | Jan 24, 2018

Last week, Walmart announced the launch of an opioid disposal solution, DisposeRx in an effort to curb prescription drug misuse. In addition to providing counseling and informational materials on proper use of opioid medications, Walmart will become the first national pharmacy retailer to offer a new opioid disposal solution. Walmart also intends to offer naloxone behind its pharmacy counters for sale or dispensing by pharmacists in states where practice laws allow it by the end of January.

Nearly 11 million people misused prescription pain relievers in 2016.[i] ASAM applauds Walmart’s actions to combat the opioid epidemic and we hope the debut of DisposeRx will offer patients new solutions to prevent prescription drug misuse.

“It’s important to get unneeded controlled substances out of our medicine cabinets across the country. This is true for opioids as well as other drugs of abuse like sedatives and sleeping pills which are contributing to the development of addiction and to unnecessary deaths. The lack of safe disposal systems represents a huge gap that needs to be filled. Walmart’s initiative will go a long way to get these medications out of easy reach of those for whom they were not prescribed,” said Dr. Kelly Clark, president of ASAM.

Dr. Shawn Ryan, president of the Ohio Society of Addiction Medicine (OHSAM) and Chair of ASAM’s Payer Relations Committee had this to say about Walmart’s announcement:

“This move by Walmart is a positive step towards preventing prescription drug misuse in Ohio and in the rest of the United States. Walmart’s footprint is enormous, and its pharmacies are critical instruments in prevention, treatment, and saving lives. ASAM is excited about this innovative step to address prescription drug misuse and we are hopeful that it will address a key component of the opioid epidemic.”

You can learn more about DisposeRx here.

[1] SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016.